Genetics

Unlocking the female bias in lupus

The majority of lupus patients are female, and new findings from Montserrat Anguera of the School of Veterinary Medicine and colleagues shed light on why. The research suggests that female lupus patients don’t fully silence their second X chromosome in T cells, leading to an immune response gone awry.

Katherine Unger Baillie

A shared past for East Africa’s hunter-gatherers

PIK Professor Sarah Tishkoff, Laura Scheinfeldt, and Sameer Soi use data from 50 populations to study African genetic diversity. Their analysis suggests that geographically far-flung hunter-gatherer groups share a common ancestry.

Katherine Unger Baillie

The diversity of rural African populations extends to their microbiomes

In the largest study of its kind, researchers led by PIK Professor Sarah Tishkoff, Matthew Hansen, and Meagan Rubel investigated the gut microbiomes of people from Botswana and Tanzania, and illuminate the impact of lifestyle, geography, and genetics in shaping the microbiome.

Katherine Unger Baillie

Using fat cells to predict response to anti-diabetes drugs

In a new study, a team of researchers have demonstrated—using fat cells derived from human stem cells—that individual genetic variation can be used to predict whether the TZD rosiglitazone will produce the unwanted side effect of increasing cholesterol levels in certain individuals.

Penn Today Staff

Why we have hair here, but not there

A new study answers a fundamental question in human evolution about how and where hair grows on the body, and reveals the existence of a naturally-occurring inhibitor to hair growth.

Penn Today Staff



In the News


The Washington Post

FDA approves two sickle cell therapies, including first CRISPR medicine

Kiran Musunuru of the Perelman School of Medicine says that gene editing will be the biggest story of the century.

FULL STORY →



Philadelphia Inquirer

More than 260,000 Penn Medicine patients have agreed to share their DNA for research, and the discoveries are just getting started

More than 260,000 people have signed up to participate in Penn Medicine BioBank, co-directed by Marilyn Ritchie and Dan Rader, which cross-references DNA with electronic health records to discover genetic variants of medical conditions.

FULL STORY →



Philadelphia Inquirer

Jim Wilson has two new promising gene therapy studies, but says investment in the cutting-edge field has ‘gotten worse’

Jim Wilson of the Perelman School of Medicine has published two new studies supporting the promise of cutting-edge gene therapy, finding evidence that the genetic treatments can be beneficial for years without raising the risk of cancer.

FULL STORY →



Smithsonian Magazine

Famed 5,300-year-old Alps Iceman was a balding middle-aged man with dark skin and eyes

Iain Mathieson of the Perelman School of Medicine says that the Iceman genome was one of the first ancient human genomes ever published.

FULL STORY →



WHYY (Philadelphia)

Philly gene therapy companies tap into city’s workforce training program for lab techs

Penn Medicine is noted for spearheading gene therapy for cancer treatment, being the first in the nation to use a gene editing tool to combat cancer in 2019.

FULL STORY →



Philadelphia Inquirer

These eight diseases are so rare that drug firms haven’t tried treating them with gene therapy. A $97 million program aims to help

Gene therapy for a rare form of blindness will be tested at Penn Medicine while gene therapy for a condition that causes skeletal deformities and seizures will be tested at the Children’s Hospital of Philadelphia.

FULL STORY →